je.st
news
AstraZeneca plc (AZN) Earns "Outperform" Rating from BNP Paribas
2015-11-30 21:21:56| Biotech - Topix.net
's stock had its "outperform" rating reaffirmed by research analysts at BNP Paribas in a research note issued to investors on Monday, AnalystRatings.NET reports. AstraZeneca plc traded up 0.09% during trading on Monday, reaching $34.08.
Tags: rating
plc
earns
bnp
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||